Updated Oct. 20, 2009 at 8:35 a.m.

Premium Lock Durham firm develops intravenous H1N1 vaccine

Published: 2009-10-20 07:30:00
Updated: 2009-10-20 08:35:19

Print this blog post
BioCryst BioCryst

BioCryst Pharmaceuticals Chief Executive Jon Stonehouse said its experimental drug Peramivir could be a tool to battle the H1N1 pandemic....

Read More
Read More

Copyright 2014 WRAL Tech Wire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Vivek Wadhwa
Commentary
Frank Vinluan
Life science
Dr. Mike Walden
Tech economy
Scroll